‘They don’t have enough’ – schools in England are running food banks for families 
Airbus Recruits Former JetBlue CEO Robin Hayes to Lead North American Operations 
General practice is in crisis in the UK – and it’s failing the people who need it most 
Sitting is bad for your health and exercise doesn’t seem to offset the harmful effects 
BYD Unwraps New Electric Pickup Truck It Named BYD Shark 
Digital trade protocol for Africa: why it matters, what’s in it and what’s still missing 
Hollys Brews Expansion with First Overseas Outlet in Japan in May 
The hidden racist history of hair loss 
Online wellness content: 3 ways to tell evidence-based health information from pseudoscience 
Germany decriminalised cannabis: why the UK should consider doing the same 
Japan Posts 7.7% Growth in Machinery Orders 
US Govt to Block Tapestry's $8.5 Billion Takeover of Capri Holdings 
Kroger and Albertsons Extend Store Sale to C&S by 166 Stores in Push for Merger Approval 
Fifty-seven lawsuits alleging that hair relaxer products sold by L'Oreal USA Inc and two India-based firms cause cancer and other health problems will be consolidated before US District Judge Mary Rowland in Chicago,
The Chicago federal court will streamline discovery efforts and other pretrial issues for the cases, according to the order.
The lawsuits, which have been filed in federal courts across the country, alleged that the companies knew about the dangerous chemicals in their products but marketed and sold them anyway.
The cases name the US subsidiary of L'Oreal SA and subsidiaries of India-based companies Godrej SON Holdings Inc. and Dabur International Ltd.
Representatives for the companies opposed the centralization of the cases.
L'Oreal said it is confident in the safety of its products and that lawsuits against it have no legal merit.
The claims come in response to a National Institutes of Health research that was published in October and revealed that women who used the products frequently had a greater than doubled risk of developing uterine cancer.
The panel's decision, according to Diandra Debrosse Zimmermann of DiCello Levitt, who filed the initial case after the study's publication, "recognized the clear benefits of centralizing the hair relaxer litigation," and she anticipates that many more companies will do the same in the upcoming weeks.
As the goods are often promoted to women of color, Zimmermann expects hundreds of women may end up suing over them.
